~~<i id='ECAF2E4BBC'><strike id='ECAF2E4BBC'><tt id='ECAF2E4BBC'><pre id='ECAF2E4BBC'></pre></tt></strike></i>~~

Home» knowledge» explore

explore

author：knowledge 2025-10-02 19:04:35 Page View：768

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： WATCH: Why do our ears pop?
Next article： Duchenne breakthrough therapy leaves behind pioneering families

explore

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

AbbvieCEORichardGonzalezwillstepdowninJuly.JacquelynMartin/APAbbVieannouncedTuesdaythatCEORichardGon

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

High breast density mammograms need follow

BENOITDOPPAGNE/BELGAMAG/AFPviaGettyImagesMillionsofAmericanwomenoverage40receiveregularmammogramstos